ACADIA Pharmaceuticals (ACAD) Nukunuku Sɛn
Prévision IA: ACAD
AI ɖo nɔvɔxɔsisa ɖo xɔsin ɖo gbe ɖagbe, xɔsin ɖo xwe ɖagbe, kpodo xɔsin ɖo xwe ɖagbe kpo. Xɔsin ɖo xɔsin ɖo xɔsin ɖo xɔsin. Xɔsin ɖo xɔsin ɖo xɔsin, ɖo xɔsin ɖo xɔsin.
Prix sur les 6 derniers mois
Premium affiche les objectifs de prix de l'IA pour 1 jour, 1 semaine et 1 mois pour cette action et toutes les autres.
Déverrouiller Premium🔒 Nukunukunukunukunuku
The forecast track record — every past forecast next to the actual close — is part of Premium.
Déverrouiller PremiumGɔn Kɛntɔn E Nɔví
ACADIA Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development and commercialization of small-molecule drugs for the treatment of central nervous system disorders, including dysfunctions caused by Parkinson’s disease, schizophrenia, neuropathic pain, and glaucoma.